BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 37483613)

  • 21. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications.
    Mengstie MA; Chekol Abebe E; Behaile Teklemariam A; Tilahun Mulu A; Agidew MM; Teshome Azezew M; Zewde EA; Agegnehu Teshome A
    Front Mol Biosci; 2022; 9():1002710. PubMed ID: 36188225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
    Obrosova IG; Julius UA
    Curr Vasc Pharmacol; 2005 Jul; 3(3):267-83. PubMed ID: 16026323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.
    Kang Q; Yang C
    Redox Biol; 2020 Oct; 37():101799. PubMed ID: 33248932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Alpha-lipoic Acid Supplementation in the Prevention of Diabetes Complications: A Comprehensive Review of Clinical Trials.
    Jeffrey S; Samraj PI; Raj BS
    Curr Diabetes Rev; 2021; 17(9):e011821190404. PubMed ID: 33461470
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Huang H; Luo Y; Wang Q; Zhang Y; Li Z; He R; Chen X; Dong Z
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.
    Testa R; Bonfigli AR; Prattichizzo F; La Sala L; De Nigris V; Ceriello A
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular death, reactive oxygen species (ROS) and diabetic complications.
    Volpe CMO; Villar-Delfino PH; Dos Anjos PMF; Nogueira-Machado JA
    Cell Death Dis; 2018 Jan; 9(2):119. PubMed ID: 29371661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes.
    Takenaka K; Yamagishi S; Matsui T; Nakamura K; Imaizumi T
    Curr Neurovasc Res; 2006 Feb; 3(1):73-7. PubMed ID: 16472128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of inflammatory cytokines in diabetes and its complications.
    King GL
    J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative association between erythrocyte reduced glutathione concentration and diabetic complications.
    Thornalley PJ; McLellan AC; Lo TW; Benn J; Sönksen PH
    Clin Sci (Lond); 1996 Nov; 91(5):575-82. PubMed ID: 8942396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development.
    Du C; Whiddett RO; Buckle I; Chen C; Forbes JM; Fotheringham AK
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
    Kaabi YA
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of diabetes: identification of markers for early detection, glycemic control, and monitoring clinical complications.
    Wu JT
    J Clin Lab Anal; 1993; 7(5):293-300. PubMed ID: 8410489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic Neuropathy of the Retina and Inflammation: Perspectives.
    Bikbova G; Oshitari T; Bikbov M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.
    Vivekanadan-Giri A; Wang JH; Byun J; Pennathur S
    Rev Endocr Metab Disord; 2008 Dec; 9(4):275-87. PubMed ID: 18752069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced glycation end products and diabetic complications.
    Stitt AW; Jenkins AJ; Cooper ME
    Expert Opin Investig Drugs; 2002 Sep; 11(9):1205-23. PubMed ID: 12225243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).
    Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I
    J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous metabolic route for diabetic patients.
    Nogueira-Machado JA; Chaves MM
    Expert Opin Ther Targets; 2008 Jul; 12(7):871-82. PubMed ID: 18554155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Water Soluble Vitamins and their Role in Diabetes and its Complications.
    Deshmukh SV; Prabhakar B; Kulkarni YA
    Curr Diabetes Rev; 2020; 16(7):649-656. PubMed ID: 31526351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.